Ensign Group, Inc (ENSG)
- Sector
- Health Care
- Last price
- $184.11
- As of
Kresmion compiles this page from ENSG's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
ENSIGN GROUP, INC (ENSG): 7 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-10-27.
See the full ENSG dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for ENSG on one page. Preview it with sample data, then open it live with a free account.
Preview the ENSG dossierActive events for ENSG
- high13F: funds added
7 tracked funds increased ENSG this 2026Q2, institutional consensus
- mediumTrend spike
ENSIGN GROUP, INC search volume spiked +100 pts, unusual interest
- high13F: funds added
6 tracked funds increased ENSG this 2026Q2, institutional consensus
- high13F: large increase
CITADEL ADVISORS LLC added +86% to ENSG (2026Q2)
- high13F: large increase
CITADEL ADVISORS LLC added +1449% to ENSG (2026Q2)
FREE, NO ACCOUNT
Every event on ENSG, as it fires
You are seeing 5 of 17 events recorded on ENSG since 2026-07-24.
The five above landed across 3 days. The other 12 were recorded on 1 other days. 12 of the 17 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in ENSG (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| Point72 Asset Management, L.P.CUSIP 29358P101 · 2026Q2 | $49.8M | 0.05% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 29358P101 · 2026Q2 | $38.3M | 0.01% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 29358P101 · 2026Q2 | $25.1M | 0.02% | , |
| CITADEL ADVISORS LLCCUSIP 29358P101 · 2026Q2 | $24.9M | 0.00% | , |
| D. E. Shaw & Co., Inc.CUSIP 29358P101 · 2026Q2 | $11M | 0.01% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 29358P101 · 2026Q2 | $5.7M | 0.01% | , |
| Bridgewater Associates, LPCUSIP 29358P101 · 2026Q2 | $2M | 0.01% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, ENSG
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
ENSG against its peers
ENSG's operating margin of 8.5% ranks in the 52nd percentile of 23 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-03-31.
| Metric | ENSG | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 5.0B USD | 1.5B USD | 71 | 25 |
| Gross margin | 20.1% | 59.0% | 18 | 19 |
| Operating margin | 8.5% | 7.8% | 52 | 23 |
| Net margin | 6.8% | 4.1% | 60 | 25 |
| Return on equity | 15.4% | 11.2% | 62 | 24 |
| P / E | 31.5x | 39.2x | 38 | 16 |
Peers (25): GKOS, MOH, BTSG, EHC, MASI.D, HNGE, PEN, PACS, CHE, HIMS, LNTH, DOCS, TFX, RDNT, WAY, MMSI, HAE, THC, GH, OPCH, LIVN, ITGR, CRVL, IRTC, MDLN. Fiscal periods ending between 2025-12-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (ENSG: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow ENSG on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to ENSG for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.